# G3: Wave 8 Quality Review â€” Synthesis Layer 2 (Integration)

**Reviewer:** G3 Quality Gate
**Date:** 2026-02-19
**Scope:** 3 Wave 8 files (SL2a, SL2b, SL2c) evaluated against citation integrity, scope discipline, content quality, cross-file consistency, plus 3 spot-checks
**Input Files:** SL2a, SL2b, SL2c; verified against SL1a, SL1b, SL1c, CC4

---

## SL2a: Executive Narrative Review

**File:** `/Users/nicholaspate/Documents/01_Active/Corp_Strat/ezAI/isv_development/analysis/review/SL2a_executive_narrative.md`

- **Score:** PASS
- **Citation integrity:** Strong. Every factual claim references a specific source file, section, and subsection. Citation chains are traceable: for example, the P1 Phase 3 TE adjustment chain runs SL2a Section 1.1 -> SL1c Section 2.1 -> GT1 FTE data, and each link is explicitly documented. The file cites 6 primary sources (SL1a, SL1b, SL1c, RP2c, RP4b, CC2) and correctly attributes individual data points to the specific section within those sources. No orphan claims were found.
- **Scope discipline:** Clean. SL2a evaluates the executive narrative in Section 8 of the ratings file and proposes revised finding text. It does not re-derive any individual ratings. The proposed revised findings reference rating adjustments from other agents (SL1a, SL1c) but do not independently perform the analysis that produced those adjustments. The file correctly draws a line between "assessment of the narrative" and "re-derivation of ratings" throughout.
- **Content quality:** Excellent. The finding-by-finding assessment goes well beyond surface description. Each finding receives a verdict (SUPPORTED, PARTIALLY SUPPORTED), specific arithmetic verification, qualification of the original framing, and a concrete proposed revision. The identification of five arc weaknesses (Section 5.3) is analytically sophisticated -- particularly Weakness 2 (Finding 4 creates false comfort on AI infrastructure) and Weakness 3 (six absent risk categories are invisible). The proposed revised findings (Section 6) are actionable and include tracked sources for each revision. The new Finding 7 (systematic direction of error) fills a genuine analytical gap.
- **Cross-file consistency:** Consistent with SL2c. SL2a's proposed Phase 3 grand total of "approximately 51-95 FTE" in the revised narrative (Section 7, revised Finding 7) does not incorporate the DS9 scope correction that SL2c resolves. SL2c produces a corrected grand total of ~50-93 FTE after the DS9 FTE reduction. This is a minor sequencing issue: SL2a was written before SL2c's DS9 resolution was finalized, and the two files give different grand totals. See Cross-File Consistency Notes below for details.
- **Issues found:**
  1. **Grand total inconsistency with SL2c.** SL2a Section 7 revised Finding 7 states "corrected Phase 3 grand total is approximately 51-95 FTE (revised from ~49-93)." SL2c Section 1.1 corrects this further to ~50-93 FTE after the DS9 scope fix. The two files produce different Phase 3 grand totals because SL2a incorporates the P3 FTE arithmetic correction (11.85-19.55) but not the DS9 scope correction (which reduces P3 FTE back to 10.35-17.30). This is not an analytical error in SL2a -- it correctly reflects SL1c's finding -- but the revised narrative text should be updated to reflect SL2c's final corrected figure.
  2. **P2 FTE low bound inconsistency.** SL2a Section 1.6 states "P2: 18.6-35.6 FTE" multiple times. SL1c Section 4.2 notes P2 low bound is 18.55, rounded to 18.6. SL2c Section 3.3 uses 18.55. This is a minor rounding inconsistency (0.05 FTE) with no strategic impact, but the file is internally inconsistent in its level of rounding precision.
- **Fix recommendations:** Update SL2a Section 7 revised Finding 7 to reflect SL2c's final corrected Phase 3 grand total (~50-93 FTE). Add a footnote acknowledging that the DS9 scope correction (SL2c Section 1.1) supersedes the SL1c aggregate for the P3 FTE figure.

---

## SL2b: Consolidated Interview Validation Guide

**File:** `/Users/nicholaspate/Documents/01_Active/Corp_Strat/ezAI/isv_development/analysis/review/SL2b_interview_guide.md`

- **Score:** PASS
- **Citation integrity:** Strong. Each of the 35 questions carries an explicit source attribution (e.g., "Source: SL1a Section 4 (from RP1e)" for Q1, "Source: RP1a (CP-01 Phase 2 Medium confidence)" for Q2). The cross-reference table in the final section maps every proposed rating adjustment to specific interview questions, with source citations for each. No unsourced claims were identified.
- **Scope discipline:** Clean. SL2b compiles interview questions from SL1a, SL1b, SL1c, and underlying review agents. It does not perform new analysis, derive new ratings, or assess the validity of any finding. The file correctly stays within interview guide compilation scope. The "Top 10 Must-Ask" prioritization is based on confidence impact (number of ratings each question would resolve), which is an appropriate organizing criterion for an interview guide.
- **Content quality:** Strong. The guide is operationally actionable: it specifies target interviewee profiles (mid-size ISV, 50-500 employees, 10+ on-premises deployments), session logistics (60 min max, semi-structured format), and a minimum viable interview set (3 roles, 3 sessions, ~3 hours). The three-tier priority system (Tier 1: 3+ ratings, Tier 2: 1-2 ratings, Tier 3: validation only) is well-reasoned and maps directly to the review's confidence gaps. The cross-reference table mapping proposed adjustments to interview questions (Section "Cross-Reference: Questions to Proposed Rating Adjustments") is the most valuable structural element -- it ensures no proposed adjustment goes unvalidated.
- **Cross-file consistency:** Consistent with SL2c's proposed changes. The cross-reference table lists all 10 rating cell changes from SL2c Section 6.1, plus the P3 FTE aggregate correction and Phase 2 total revision. The Phase 2 total revision in SL2b ("12-25 pw") differs from SL2c's characterization of SL1b's proposal ("12-25 person-weeks for median customers and 15-30 for air-gapped/regulated customers"), but this is because SL2b's table uses a single row for Phase 2, whereas SL2c correctly distinguishes median from air-gapped/regulated. Not a contradiction -- a compression issue in the cross-reference table.
- **Issues found:**
  1. **Q4 Phase 3 FTE range uses pre-DS9 figure.** Q4 asks the VP Engineering to validate "51-95 FTE range projected here." SL2c's corrected grand total is ~50-93 FTE. The interview question references a figure that should be updated to reflect the DS9 scope correction.
  2. **Minimum viable interview set claims to cover 9 of Top 10 but actually covers 8.** The minimum viable set lists 3 interviews covering "9 of the Top 10 questions (missing Q6 and Q10)." That is 8 of 10 covered by 3 interviews, then the 4th interview covers Q6 and Q10 for 10 of 10. The parenthetical should read "missing Q6 and Q10" = 8 of 10, not 9 of 10.
  3. **Phase 2 total adjustment in cross-reference table.** The cross-reference table shows "Phase 2 total: 10-21 pw -> 12-25 pw." SL1b Section 2.3 proposes "12-25 person-weeks (median); 15-30 person-weeks (air-gapped/regulated)." The table omits the air-gapped/regulated range, which is the more important planning figure per SL2a's assessment that air-gapped/regulated customers are disproportionately likely to require on-premises deployment. This is a compression issue, not an error.
- **Fix recommendations:**
  1. Update Q4 (VE-2) to reference the corrected ~50-93 FTE range from SL2c.
  2. Correct the minimum viable interview claim from "9 of the Top 10" to "8 of the Top 10" for the 3-interview scenario.

---

## SL2c: Cross-Phase Integration and Reconciliation

**File:** `/Users/nicholaspate/Documents/01_Active/Corp_Strat/ezAI/isv_development/analysis/review/SL2c_cross_phase_integration.md`

- **Score:** PASS
- **Citation integrity:** Strong. The DS9 conflict resolution (Section 1.1) traces the full chain: CC4 Section 5 identifies the scope issue -> SL1b Section 2.4 documents the correction recommendation -> SL1c Section 3 carries the uncorrected figure -> SL2c performs the reconciliation with step-by-step arithmetic and per-subsegment verification. The cross-phase consistency verification table (Section 7) cites the source for every check. All 14 checks in that table carry specific source references.
- **Scope discipline:** Clean. SL2c stays within cross-phase integration scope. It resolves a conflict between SL1b and SL1c (DS9 FTE), assesses the three-phase model's structural soundness (Section 2), evaluates the two-cost-type finding (Section 3), and documents team composition transitions (Section 4). It does not duplicate per-phase findings -- instead, it synthesizes them into cross-phase insights. The file explicitly notes where it inherits findings from per-phase agents versus where it produces new cross-phase analysis.
- **Content quality:** Excellent. The DS9 conflict resolution (Section 1.1) is the strongest analytical contribution: it identifies the root cause (scope correction identified by CC4 but not propagated into SL1c's arithmetic), performs step-by-step arithmetic verification with per-subsegment decomposition, and assesses materiality (1-2 FTE, 2-3% of total). The "Two Cost Types" analysis (Section 3) produces a genuinely new insight -- the 60/40 split between linear-with-N costs and fixed product-development costs -- that was implicit in earlier analysis but never quantified. The skill transition analysis (Section 4) is strategically valuable: it identifies that Phase 3 is a staffing expansion, not a staffing reduction, which directly contradicts a common executive assumption.
- **Cross-file consistency:** The DS9 correction is the primary reconciliation between SL1b and SL1c, and SL2c resolves it explicitly. The corrected Phase 3 grand total (~50-93 FTE) is arithmetically verified. The 14-row cross-phase consistency verification table (Section 7) documents every cross-phase check and its outcome. One subtlety: SL2c Section 6.2 states the corrected P3 Phase 3 FTE aggregate as "~10-17 FTE (10.35-17.30)" while using the rounded label "~10-17" -- the pre-correction stated value was also "~10-18." The label rounds to the same tens digit at the lower bound, creating possible ambiguity with the uncorrected value. Using "~10.5-17.5" or the precise "10.35-17.30" in the rounded label would avoid confusion.
- **Issues found:**
  1. **P3 FTE rounded label ambiguity.** Section 6.2 lists the corrected P3 FTE as "~10-17 FTE" while the uncorrected was "~10-18 FTE." The lower bound rounds identically (10 vs 10), which could confuse a reader who is scanning for the correction. The precise values (10.35-17.30 vs 11.85-19.55) are clearly different, but the rounded labels obscure the lower-bound change.
  2. **Phase 3 Grand Total label.** Section 6.2 shows "~50-93 FTE" as the fully corrected grand total. The pre-DS9, post-P3-arithmetic-correction figure from SL1c was "~51-95 FTE." The precise computation in Section 1.1 yields 49.35-92.35, which SL2c rounds to "~50-93." This is arithmetically correct. However, the Summary table in Section 6.2 also shows the "SL1c Corrected (pre-DS9 scope fix)" column as "~51-95" which is the SL1c value. This is correct and internally consistent.
- **Fix recommendations:** Consider changing the rounded P3 FTE label in Section 6.2 from "~10-17 FTE" to "~10.5-17 FTE" or simply using the precise "10.35-17.30 FTE" to avoid ambiguity with the uncorrected "~10-18 FTE" label.

---

## Spot-Check Results

### Spot-Check 1: SL2a's Claim About P1 Phase 3 Avg TE Rising from 4.1 to 4.5

- **Claim tested:** SL2a Section 1.1 states: "These adjustments raise the P1 Phase 3 average TE from 4.1 to 4.5." The claim is repeated in SL2a Section 2 with a table showing Current Phase 3 TE of 4.1 and Proposed Phase 3 TE of 4.5. SL2a cites "SL1c_phase3_consolidated.md, Section 2.1" and "SL1c_phase3_consolidated.md, Section 3, Grand Summary table."
- **Source checked:** SL1c Section 1.1 (P1 Phase 3 averages), Section 2.1 (recommended adjustments), Section 3 (Grand Summary table), Section 4.3 (impact of rating changes on averages).
- **Result:** MATCH
- **Details:**
  - SL1c Section 1.1 states "Phase 3 P1 averages: RD 4.0 / TE 4.1" -- confirming the pre-adjustment TE of 4.1.
  - SL1c Section 2.1 lists the four P1 TE adjustments: CP-03 TE 4->5, CP-06 TE 3->4, CP-08 TE 3->4, CP-10 TE 4->5. Each adjustment is +1.
  - SL1c Section 3, P1 table, shows Current TE avg as 4.1 and Proposed TE as 4.5 (line 152).
  - SL1c Section 4.3 confirms: "P1 Phase 3 TE avg: 4.1 -> 4.5 (four TE +1 adjustments across 10 subsegments)."
  - Arithmetic verification: Original P1 Phase 3 TE sum = 41 (from 10 subsegments). Four +1 adjustments = +4. New sum = 45. 45/10 = 4.5. Confirmed.
  - SL2a's claim is exactly matched by SL1c across multiple sections.

### Spot-Check 2: SL2c's DS9 FTE Resolution -- Corrected to 0.50-1.00 and P3 Aggregate to 10.35-17.30

- **Claim tested:** SL2c Section 1.1 states DS9 FTE should be corrected from 2.00-3.25 to 0.50-1.00, reducing P3 Phase 3 FTE aggregate from 11.85-19.55 to 10.35-17.30, and the Phase 3 grand total from ~51-95 FTE to ~50-93 FTE (49.35-92.35).
- **Sources checked:**
  - SL1c Section 1.3 and Section 3 (DS9 FTE figures)
  - SL1c Section 4.1 (P3 FTE aggregate)
  - CC4 Section 5 (DS9 scope discrepancy)
  - CC4 Section 10, Ambiguity 2 (DS9 FTE recommended correction)
  - SL1b Section 2.4 (DS9 FTE correction recommendation)
- **Result:** MATCH
- **Details:**
  - SL1c Section 3, P3 table, line 182: DS9 shows Research FTE as "2.00-3.25" -- confirming the uncorrected SL1c figure.
  - SL1c Section 4.1: States P3 Phase 3 FTE corrected aggregate as 11.85-19.55, with DS9 contributing 2.00 (low) and 3.25 (high). This confirms SL2c's "SL1c Value" column.
  - CC4 Section 5: States DS9 FTE of 2.00-3.25 was computed from `P3_data_plane.md` under ISV-manages-GPU assumptions including "MIG partitioning, NVLink topology management, firmware updates, thermal monitoring, RMA processes." CC4 identifies this as a scope-boundary artifact.
  - CC4 Section 10, Ambiguity 2: Recommends recomputing DS9 ISV FTE, estimating it falls in "the 0.5-1.0 FTE range, consistent with a difficulty 3/5 rating."
  - SL1b Section 2.4: Confirms "DS9 Phase 3 FTE of 2.0-3.25 is carried from a pre-scope-split estimate and should be recomputed to approximately 0.5-1.0 FTE under customer-owns-GPU assumptions."
  - SL2c's arithmetic verification: Low bound 11.85 - 1.50 (DS9 reduction from 2.00 to 0.50) = 10.35. High bound 19.55 - 2.25 (DS9 reduction from 3.25 to 1.00) = 17.30. Confirmed.
  - SL2c provides a per-subsegment verification sum: DS1 1.50 + DS2 0.60 + DS3 0.40 + DS4 0.25 + DS5 0.40 + DS6 1.50 + DS7 0.70 + DS8 1.25 + DS9 0.50 + DS10 3.25 = 10.35. Arithmetic verified.
  - Grand total: P1 20.0-38.0 + P2 18.55-35.60 + P3 10.35-17.30 + P4 0.45-1.45 = 49.35-92.35, rounded to ~50-93. Confirmed.
  - The DS9 FTE correction is traceable through a clean chain: CC4 Section 5 -> SL1b Section 2.4 -> SL2c Section 1.1.

### Spot-Check 3: SL2b's "Top 10 Must-Ask" Questions Cover 3+ Rating Adjustments Each

- **Claim tested:** SL2b Executive Summary states each Top 10 question "would resolve uncertainty across 3 or more ratings if answered empirically." Individual questions carry specific "Validates" lists and "Priority Tier: Tier 1 -- changes 3+ ratings if answered" or "Tier 1 -- changes 5+ ratings if answered."
- **Source checked:** SL2c Section 6.1 (all 10 proposed rating cell changes), SL2b cross-reference table, and the "Validates" field for each Top 10 question.
- **Result:** PARTIAL MATCH
- **Details:**
  - Q1 (Aggregate Phase 1 Effort): Claims "changes 5+ ratings if answered." Validates: P1 aggregate effort (72-149 pm), parallelization factor, P1 Phase 1 averages (RD 4.4, TE 4.0). This validates the aggregate, not individual cell ratings. The "5+" claim counts the 10 P1 Phase 1 cells that the aggregate encompasses, which is reasonable but indirect. The question does not directly validate any of SL2c's 10 specific rating cell changes.
  - Q4 (Phase 3 FTE Headcount): Claims "changes 5+ ratings if answered." Validates: Phase 3 grand total, P2 divergence, all Phase 3 FTE ranges. Similar to Q1: this validates aggregate figures rather than specific cell ratings. It indirectly touches all Phase 3 ratings but does not directly confirm or refute individual proposed changes.
  - Q7 (IAM FTE at Scale): Claims "changes 3+ ratings if answered." Validates: CP-03 Phase 3 TE=4 (proposed 5), CP-03 Phase 2 TE=3, security cluster FTE deduplication. This directly validates one of SL2c's proposed changes (CP-03 Phase 3 TE 4->5) and touches 2 additional ratings. Confirmed: 3+ ratings.
  - Q6 (AI/ML Orchestration): Claims "changes 3+ ratings if answered." Validates: AL09 Phase 3 RD=3 (proposed 4), CP-07 scope boundary, P2 Phase 3 systematic divergence. Directly validates one of SL2c's proposed changes (AL09 Phase 3 RD 3->4) plus 2 adjacent ratings. Confirmed: 3+ ratings.
  - Q10 (Temporal/DLQ Ownership): Claims "changes 1-2 ratings if answered." Validates: AL05 Phase 3 RD=2 (proposed 3), Temporal config drift. Directly validates one SL2c proposed change. This is actually Tier 2, not Tier 1. But Q10 is listed as Tier 2 in the table, which is correct.
  - Assessment: The "Top 10" claim that each resolves "3 or more ratings" is defensible for questions that directly target specific cell ratings (Q7, Q6, Q2, Q3, Q5). For aggregate-level questions (Q1, Q4), the "3+" claim counts indirect validation of multiple cells through a single aggregate answer, which is a reasonable interpretation but less precise than direct cell-level validation. The Tier 1/Tier 2 classification within the Top 10 is internally consistent. Q8, Q9, and Q10 are correctly labeled as Tier 2 (1-2 ratings).
  - Cross-check against SL2c proposed changes: The cross-reference table in SL2b maps all 10 of SL2c's rating cell changes to at least one interview question. No proposed adjustment is left uncovered by the interview program.
  - Discrepancy: The Executive Summary states "each would resolve uncertainty across 3 or more ratings." This is overstated for Q8 (Tier 2, 1-2 ratings), Q9 (Tier 2, 1-2 ratings), and Q10 (Tier 2, 1-2 ratings). The "3 or more" claim applies to the Tier 1 subset (Q1-Q7), not to all 10. The individual question entries correctly label Q8-Q10 as Tier 2, but the Executive Summary incorrectly generalizes.

---

## Summary

- **Files passing:** 3 of 3
- **Files with minor issues:** 3 (SL2a, SL2b, SL2c -- all minor)
- **Files needing rework:** 0

### Issue Inventory

| File | Issue | Severity | Fix Effort |
|---|---|---|---|
| SL2a | Grand total uses ~51-95 FTE (pre-DS9 correction); SL2c produces ~50-93 | Minor | Update 2 lines in Section 7 |
| SL2a | P2 FTE low bound inconsistency (18.6 vs 18.55) | Trivial | Standardize rounding |
| SL2b | Q4 references "51-95 FTE" instead of corrected ~50-93 | Minor | Update 1 line |
| SL2b | Minimum viable set claims "9 of Top 10" should be "8 of Top 10" | Minor | Update 1 line |
| SL2b | Executive Summary overstates that all Top 10 resolve "3+" ratings; Q8-Q10 are Tier 2 | Minor | Qualify the sentence |
| SL2b | Phase 2 cross-reference table omits air-gapped/regulated range | Trivial | Add parenthetical |
| SL2c | P3 FTE rounded label "~10-17" ambiguous vs. uncorrected "~10-18" | Minor | Use precise figure |

### Cross-File Consistency Notes

1. **Grand total discrepancy.** SL2a produces ~51-95 FTE (incorporating SL1c's P3 arithmetic correction but not the DS9 scope correction). SL2c produces ~50-93 FTE (incorporating both corrections). This is a sequencing artifact, not an analytical disagreement. SL2c's figure is authoritative as the final reconciliation layer. SL2a's revised narrative (Section 7) should be updated to match SL2c.

2. **Rating adjustment coverage.** SL2b's cross-reference table covers all 10 of SL2c's proposed rating cell changes, all 3 FTE corrections, and the aggregate Phase 2 effort revision. No proposed change lacks interview validation coverage.

3. **No contradictions identified.** The three files are analytically aligned on all substantive findings: Phase 3 TE systematic understatement, P2 planning trap mechanism, P4 residual obligations, DS9 scope correction, and the direction-of-error meta-finding. Differences are limited to rounding conventions and which intermediate correction stage (pre- vs. post-DS9) a given figure reflects.

4. **SL2a narrative assessment is consistent with SL2c structural changes.** SL2a's revised Finding 4 ("structurally reduced but not eliminated") aligns with SL2c's treatment of P4 residual obligations. SL2a's revised Finding 7 (systematic understatement) aligns with SL2c Section 5 (single most important finding). The narrative and structural layers reinforce rather than contradict each other.

### Overall Wave 8 Assessment

Wave 8 achieves its integration objectives. The three SL2 files successfully synthesize 27 prior agent files into executive-actionable outputs: a revised narrative with specific replacement text (SL2a), an operationally complete interview program covering all confidence gaps (SL2b), and a reconciled set of structural changes with the DS9 scope conflict resolved (SL2c). The only cross-file inconsistency -- the grand total difference between SL2a (~51-95) and SL2c (~50-93) -- is a minor sequencing artifact that requires updating 2-3 lines in SL2a. All three files pass quality review with minor issues only.

---

## Sources Consulted

| File | Absolute Path | Purpose |
|---|---|---|
| SL2a_executive_narrative.md | `/Users/nicholaspate/Documents/01_Active/Corp_Strat/ezAI/isv_development/analysis/review/SL2a_executive_narrative.md` | Wave 8 file under review |
| SL2b_interview_guide.md | `/Users/nicholaspate/Documents/01_Active/Corp_Strat/ezAI/isv_development/analysis/review/SL2b_interview_guide.md` | Wave 8 file under review |
| SL2c_cross_phase_integration.md | `/Users/nicholaspate/Documents/01_Active/Corp_Strat/ezAI/isv_development/analysis/review/SL2c_cross_phase_integration.md` | Wave 8 file under review |
| SL1a_phase1_consolidated.md | `/Users/nicholaspate/Documents/01_Active/Corp_Strat/ezAI/isv_development/analysis/review/SL1a_phase1_consolidated.md` | Spot-check 1 source verification |
| SL1b_phase2_consolidated.md | `/Users/nicholaspate/Documents/01_Active/Corp_Strat/ezAI/isv_development/analysis/review/SL1b_phase2_consolidated.md` | DS9 correction chain verification |
| SL1c_phase3_consolidated.md | `/Users/nicholaspate/Documents/01_Active/Corp_Strat/ezAI/isv_development/analysis/review/SL1c_phase3_consolidated.md` | Spot-checks 1 and 2 source verification |
| CC4_scope_consistency.md | `/Users/nicholaspate/Documents/01_Active/Corp_Strat/ezAI/isv_development/analysis/review/CC4_scope_consistency.md` | Spot-check 2 DS9 scope correction source |
